Cargando…
Intrasphincteric Botulinum Toxin Injection in Treatment of Chronic Idiopathic Constipation in Children
OBJECTIVE: Injection of botulinum toxin into the anal sphincter is a novel and safe new treatment of chronic idiopathic constipation and anal fissure in children. The purpose of this study was to determine the utility of intra sphincteric injection of botox in the treatment of children with refracto...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006509/ https://www.ncbi.nlm.nih.gov/pubmed/24800020 |
_version_ | 1782314223132475392 |
---|---|
author | Ahmadi, Javad Azary, Saeedeh Ashjaei, Bahar Paragomi, Pedram Khalifeh-Soltani, Amin |
author_facet | Ahmadi, Javad Azary, Saeedeh Ashjaei, Bahar Paragomi, Pedram Khalifeh-Soltani, Amin |
author_sort | Ahmadi, Javad |
collection | PubMed |
description | OBJECTIVE: Injection of botulinum toxin into the anal sphincter is a novel and safe new treatment of chronic idiopathic constipation and anal fissure in children. The purpose of this study was to determine the utility of intra sphincteric injection of botox in the treatment of children with refractory constipation. METHODS: All children who suffered from chronic constipation for more than three months, and who had not responded to medical treatment, were referred to pediatrics surgical clinic for surgical intervention by pediatric gastroenterologist. The patients were randomly divided into cases and control group. The control group received no injection and was only treated with stool softeners. The case group received this therapy in addition to injection. After the botox injection, patients were asked about the presence of the signs of constipation including painful defecation, vomiting, stool consistence, soiling and defecation interval. FINDINGS: Defecation of painful stool existed in 88% of patients before botox injection and it was reduced to 15% after botox injection. In the control group, 90% of patients had painful defecation, which reduced to 86% after medical treatment (P=0.0001). Stool was hard in 80% of patients before was reduced to 28% after botox injection. In the control group, it existed in 81% of children and reduced to 78% after medical treatment (P=0.0001). Soiling existed in 62% of patients before and was reduced to 8% after botox injection, but in the control group it reduced from 62% to 42.5% after medical treatment (P=0.0001). In the control group, 98% of the patients had defecation intervals more than 3 days and it was the same after medical treatment. In case group, this index before botox injection was 9.1 days, and after botox injection was reduced to 2.6 days (P=0.0001). CONCLUSION: Our study results showed that injection of botulinum toxin into anal sphincter is an effective and safe new treatment of chronic idiopathic constipation in children. |
format | Online Article Text |
id | pubmed-4006509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-40065092014-05-05 Intrasphincteric Botulinum Toxin Injection in Treatment of Chronic Idiopathic Constipation in Children Ahmadi, Javad Azary, Saeedeh Ashjaei, Bahar Paragomi, Pedram Khalifeh-Soltani, Amin Iran J Pediatr Original Article OBJECTIVE: Injection of botulinum toxin into the anal sphincter is a novel and safe new treatment of chronic idiopathic constipation and anal fissure in children. The purpose of this study was to determine the utility of intra sphincteric injection of botox in the treatment of children with refractory constipation. METHODS: All children who suffered from chronic constipation for more than three months, and who had not responded to medical treatment, were referred to pediatrics surgical clinic for surgical intervention by pediatric gastroenterologist. The patients were randomly divided into cases and control group. The control group received no injection and was only treated with stool softeners. The case group received this therapy in addition to injection. After the botox injection, patients were asked about the presence of the signs of constipation including painful defecation, vomiting, stool consistence, soiling and defecation interval. FINDINGS: Defecation of painful stool existed in 88% of patients before botox injection and it was reduced to 15% after botox injection. In the control group, 90% of patients had painful defecation, which reduced to 86% after medical treatment (P=0.0001). Stool was hard in 80% of patients before was reduced to 28% after botox injection. In the control group, it existed in 81% of children and reduced to 78% after medical treatment (P=0.0001). Soiling existed in 62% of patients before and was reduced to 8% after botox injection, but in the control group it reduced from 62% to 42.5% after medical treatment (P=0.0001). In the control group, 98% of the patients had defecation intervals more than 3 days and it was the same after medical treatment. In case group, this index before botox injection was 9.1 days, and after botox injection was reduced to 2.6 days (P=0.0001). CONCLUSION: Our study results showed that injection of botulinum toxin into anal sphincter is an effective and safe new treatment of chronic idiopathic constipation in children. Tehran University of Medical Sciences 2013-10 /pmc/articles/PMC4006509/ /pubmed/24800020 Text en © 2013 Iranian Journal of Pediatrics & Tehran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Ahmadi, Javad Azary, Saeedeh Ashjaei, Bahar Paragomi, Pedram Khalifeh-Soltani, Amin Intrasphincteric Botulinum Toxin Injection in Treatment of Chronic Idiopathic Constipation in Children |
title | Intrasphincteric Botulinum Toxin Injection in Treatment of Chronic Idiopathic Constipation in Children |
title_full | Intrasphincteric Botulinum Toxin Injection in Treatment of Chronic Idiopathic Constipation in Children |
title_fullStr | Intrasphincteric Botulinum Toxin Injection in Treatment of Chronic Idiopathic Constipation in Children |
title_full_unstemmed | Intrasphincteric Botulinum Toxin Injection in Treatment of Chronic Idiopathic Constipation in Children |
title_short | Intrasphincteric Botulinum Toxin Injection in Treatment of Chronic Idiopathic Constipation in Children |
title_sort | intrasphincteric botulinum toxin injection in treatment of chronic idiopathic constipation in children |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006509/ https://www.ncbi.nlm.nih.gov/pubmed/24800020 |
work_keys_str_mv | AT ahmadijavad intrasphinctericbotulinumtoxininjectionintreatmentofchronicidiopathicconstipationinchildren AT azarysaeedeh intrasphinctericbotulinumtoxininjectionintreatmentofchronicidiopathicconstipationinchildren AT ashjaeibahar intrasphinctericbotulinumtoxininjectionintreatmentofchronicidiopathicconstipationinchildren AT paragomipedram intrasphinctericbotulinumtoxininjectionintreatmentofchronicidiopathicconstipationinchildren AT khalifehsoltaniamin intrasphinctericbotulinumtoxininjectionintreatmentofchronicidiopathicconstipationinchildren |